Advertisement

Infection

, Volume 13, Issue 2, pp 82–84 | Cite as

Comparison of the development of experimental pyelonephritis in homozygous brattleboro diabetes insipidus rats, heterozygous control rats and normal wistar rats

  • M. Güngör
  • H. Sagduyu
  • H. Koyuncuoglu
  • Ö. Ang
  • V. Uysal
  • D. Inanç
  • M. Ang
Originalia

Summary

A comparative study was performed on haematogenous experimental pyelonephritis by injecting aStaphylococcus aureus suspension i.v. to homozygous and heterozygous Brattleboro and Wistar rats. The numbers of viable bacteria in blood, urine and kidney homogenates and the pathomorphological scores determined on the tenth day of infection were significantly lower in Brattleboro diabetes insipidus rats than in heterozygous Brattleboro and normal Wistar rats. The results suggest that homozygous Brattleboro rats are much more resistant to experimental pyelonephritis.

Keywords

Vasopressin Oxytocin Pyelonephritis Diabetes Insipidus Kidney Homogenate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Vergleich der Entwicklung einer experimentellen Pyelonephritis bei homozygoten Brattleboro-Ratten mit Diabetes insipidus, heterozygoten Kontrolltieren und normalen Wistar-Ratten

Zusammenfassung

Die Entwicklung einer hämatogenen experimentellen Pyelonephritis nach i.v. Injektion einerStaphylococcus aureus-Suspension wurde bei homozygoten und heterozygoten Brattleboro-Ratten und Wistar-Ratten in einer Vergleichsstudie geprüft. Am zehnten Tag der Infektion wurde die Zahl lebender Bakterien im Blut, Urin und in Nierenhomogenaten untersucht und eine morphologische Graduierung durchgeführt; dabei waren die Bakterienzahlen und morphologischen Veränderungen bei Brattleboro-Ratten mit Diabetes insipidus signifikant geringfügiger als bei heterozygoten Brattleboro-Ratten und bei Wistar-Ratten. Daraus läßt sich schließen, daß homozygote Brattleboro-Ratten gegen eine experimentelle Pyelonephritis wesentlich resistenter sind als die übrigen geprüften Tierstämme.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature

  1. 1.
    Valtin, H., Schroeder, A. Familial hypothalamic diabetes insipidus in rats (Brattleboro strain). Am. J. Physiol. 206 (1964) 425–430.PubMedGoogle Scholar
  2. 2.
    Kasting, N. W., Cooper, K. E., Veale, W. L. Vasopressin: a homeostatic effector in the febrile process. Neurosci. Biobehav. Rev. 6 (1982) 215–222.CrossRefPubMedGoogle Scholar
  3. 3.
    Malayan, S. A., Ramsay, D. J., Keil, L. C., Reid, I. A. Effects of increases in plasma vasopressin concentration on plasma renin activity, blood pressure, heart rate, and plasma corticosteroid concentration in conscious dogs. Endocrinology 107 (1980) 1899–1904.CrossRefPubMedGoogle Scholar
  4. 4.
    Beck, T. R., Hassid, A., Dunn, M. J. The effect of arginine vasopressin and its analogs on the synthesis of prostaglandin E2 by rat renal medullary interstitial cells in culture. J. Pharmacol. Exp. Ther. 215 (1980) 15–19.PubMedGoogle Scholar
  5. 5.
    Anhut, H., Knepel, W., Nutto, D., Hertting, G. Vasopressin stimulates release of β-lipotropin and β-endorphin in conscious rats as measured by radioimmunoassay of unexpected plasma. Naunyn-Schmiedberg's Arch. Pharmacol. 316 (1981) 59–63.CrossRefGoogle Scholar
  6. 6.
    Baertschi, A. J., Beny, J.-L., Makara, G. B. Paraventricular nucleus region controls pituitary-adrenal function in Brattleboro rats. Am. J. Physiol. 244 (1983) R363-R367.PubMedGoogle Scholar
  7. 7.
    Baertschi, A. J., Vallet, P., Baumann, J. B., Girard, J. Neural lobe of pituitary modulates corticotropin release in the rat. Endocrinology 106 (1980) 878–882.CrossRefPubMedGoogle Scholar
  8. 8.
    Buijs, R. M. Intra- and extrahypothalamic vasopressin and oxytocin pathways in the rat. Cell Tissue Res. 192 (1979) 423–435.Google Scholar
  9. 9.
    Burlet, A., Chateau, M., Czernichow, P. Infundibular localization of vasopressin, oxytocin and neurophysins in the rat: its relationships with corticotrope function. Brain Res. 168 (1979) 275–286.CrossRefPubMedGoogle Scholar
  10. 10.
    Caisova, D., Stajner, A., Suva, J. Modification of fat and carbohydrate metabolism by neurohypophyseal hormones: I. Effect of lysine-vasopressin on non-esterified fatty acid, glucose, tryglyceride and cholesterol levels in the serum of female rats. Endocrinology 76 (1980) 315–325.Google Scholar
  11. 11.
    Edwards, M. W., Brooks, S. L., Gove, C. D., Hems, D. A., Cawthorne, M. A. Effects of vasopressin on lipogenesis in obese mice. FEBS Letters 127 (1981) 25–27.CrossRefPubMedGoogle Scholar
  12. 12.
    Güngör, M., Ang, Ö., Inanç, D., Petorak, I., Koyuncuoglu, H. The effect of splenectomy on the development of experimental pyelonephritis. Experientia 37 (1981) 387–388.CrossRefPubMedGoogle Scholar
  13. 13.
    Öbek, A., Ang, Ö., Iplikçi, A., Güvener, Z., Eroglu, L., Güngör, M., Yurtkuran, M. Preventive effects of trimethoprim, sulfamethoxazole and trimethoprim-sulfamethoxazole combination on experimental pyelonephritis in rats. Chemotherapy 21 (1975) 67–72.CrossRefPubMedGoogle Scholar
  14. 14.
    Sokol, H. W., Zimmerman, E. A. The hormonal status of the Brattleboro rat. Ann. N. Y. Acad. Sci. 394 (1982) 535–548.CrossRefPubMedGoogle Scholar
  15. 15.
    Altura, B. M. Microcirculatory and vascular smooth muscle behavior in the Brattleboro rat: Relationship to reticuloendothelial system function and resistance to shock and trauma. Ann. N. Y. Acad. Sci. 394 (1982) 375–390.CrossRefPubMedGoogle Scholar
  16. 16.
    Pearlmutter, A. F., Rapino, E., Saffran, M. A semi-automatedin vitro assay for CRF activities of peptides related to oxytocin and vasopressin. Neuroendocrinology 15 (1974) 106–119.CrossRefPubMedGoogle Scholar
  17. 17.
    McCann, S. M., Antunes-Rodrigues, J., Nallar, R., Valtin, H. Pituitary-adrenal function in the absence of vasopressin. Endocrinology 79 (1966) 1058–1064.CrossRefPubMedGoogle Scholar
  18. 18.
    Thompson, J., Furth, R. V. The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J. Exp. Med. 131 (1970) 429–442.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Nettesheim, H., Hammons, A. S. Effect of immunosuppressive agents on retention of antigen in the mouse spleen. Proc. Soc. Exp. Biol. 133 (1970) 696–701.CrossRefPubMedGoogle Scholar
  20. 20.
    Wernon-Roberts, B. The effects of steroid on macrophage activity. Internat. Rev. Cytol. 25 (1969) 131–159.CrossRefGoogle Scholar

Copyright information

© MMV Medizin Verlag GmbH München 1985

Authors and Affiliations

  • M. Güngör
    • 1
  • H. Sagduyu
    • 1
  • H. Koyuncuoglu
    • 1
  • Ö. Ang
    • 2
  • V. Uysal
    • 3
  • D. Inanç
    • 4
  • M. Ang
    • 4
  1. 1.Department of PharmacologyIstanbul Medical Faculty, ÇapaIstanbulTurkey
  2. 2.Department of MicrobiologyIstanbul Medical Faculty, ÇapaIstanbulTurkey
  3. 3.Department of PathologyIstanbul Medical Faculty, ÇapaIstanbulTurkey
  4. 4.Department of MicrobiologyIstanbul Faculty of DentistryIstanbulTurkey

Personalised recommendations